Летнее коктейльное меню » Страница 25 » Андиамо сеть ресторановSexual dysfunction in the male patient with uremia: Наличие андрогенного дефицита у мужчин с СД 1 типа, получающих терапию ПГД, c,omid самостоятельным независимым фактором риска hypogonadotropic анемии; 5. Genetic risk factors in male infertility. В том числе ее влияния на предстательную железу СаггаШегБ М. Как подчеркнуто в программе правительства Российской федерации hypogonadism материнство"в среднем каждая 7-я супружеская пара dosage России на протяжении жизни сталкивается с проблемами бесплодия. Clomid J Clin Invest ; suppl. Erythropoietic response of dialyzed patients to testosterone administration. Morales A, Lunenfeld B:
Problems of Endocrinology
Abero K, Jangula J. Aluminium uptake end toxicity in cultured mouse hepatocytes. Adv Ren Replace Review. Cardiac complications of end-stage renal disease. Effect of renal transplantation on sperm quality and sex hormone levels. Review Hemodialysis in diabetic patients. Am J Kidney Dis. Acute effect of trandolapril on serum erythropoietin in uremic and hypertensive patients. American Association for Clinical Endocrinologists: AACE guidelines for evaluation and treatment of hypogonadism in adult male patients— update.
The role of androgens in the treatment of hematologic disorders. Adv Intern Med ; Erythropoietin for porphyria cutanea tarda in renal failure. Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease. Am J Kidney Dis Jan;17 l: Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin. Effects of long-term testosterone dministration on pituitary-testicular axis in end-stage renal failure.
The effects of nandrolone decanoate on nutritional parameters in hemodialysis patients. Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls. Managing the risks of prostate disease during testosterone replacement therapy in older men: The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med ; Testosterone doseresponse relationships in healthy young men.
Am J Physiol Endocrinol Metab El , Testosterone supplementation for aging-associated sarcopenia. The dose-dependent effects of testosterone on sexual function and on muscle mass and function. Mayo Clin Proc Cognitive function, mood and P3 latency: Influence of therapy with recombinant erythropoietin on serum levels of neopterin in hemodialysis subjects. A controlled trial of nandrolone decanoate in the treatment of uremic anemia. Int J Impot Res Erectile dysfunction in general medicine practice: Int J Impot Res ; Effect of chronic oral testosterone undecanoate administration on the pituitary-testicular axes of hemodialyzed male patients.
Collins AJ et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, to J Am Soc Nephrol. Lipemic and lipoproteinemic effects of natural and synthetic androgens in humans. Clin Exp Pharmacol Physiol ; Erythropoiesis and erythropoietin in patients with chronic renal failure treated with hemodialysis and testosterone. Ann Intern Med ; Effect of long-term epoetin beta therapy on the quality of life of hemodialysis patients.
Effects of uremia and dialysis on brain electrophysiology after recombinant human erythropoietin treatment. Circulating luteinizing hormone receptor inhibitor s in boys with chronic renal failure. Matsumoto, MD, Wilfred Y. Fujimoto, MD and Edward J. Low testosterone and insulin resistance in hypertension-prone men. J Hum Hypertens ; Low dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina.
Anemia is common in heart failure and is associated with poor outcomes: Erectilc dysfunction in diabetic subjects in Italy. Impotence and its medical and psychological correlates: Feldman HA, Singer I. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med ; Finkelstein JS, Klibanski A. Effects of androgens on bone metabolism. Advances in anabolic interventions for malnourished dialysis patients. The hematologic effect of androgen in uremic patients.
Ann Intern Med Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med The erythrocythaemic effects of androgens. Br J Haematol ; Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis. Ger Nephrol Urol ; 9: Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on haemodialysis?
Nephrol Dial Transplant ; Am J Kidney Dis ; Androgen deficiency in the aging male: J Steroid Biochem Mol Biol Angiographic progression of coronary artery disease in patients with endstage renal disease. Diagnostic methods in the detection of prostate cancer: Endocrinol Metab Clin North Am. Hakim R, Levin N Malnutrition in hemodialysis patients.
Am J Kidney Dis Androgen action and pharmacologic uses. DeGroot L, Jameson J eds. Handelsman DJ, Dong Q. Endocrinol Metab North Am. Harald Bergrem and Torbjorn Leivestad Diabetic nephropathy and endstage renal failure: Current therapeutic options in type 2 diabetes. Eur J Clin Invest ; suppl. N Engl J Med. Holmang A, Bjorntorp P.
The effects of testosterone on insulin sensitivity in male rats. Acta Physiol Scand ; Non-erythropoietin-based anaemia management in chronic kidney disease. Hemodynamic and volume changes by recombinant human erythropoietin in the treatment of anaemic hemodialysis patients. Is erythropoietin effective for impotence in dialysis patients? J Am Soc Nephrol ; Jackson JA, Kleerekoper M.
Psychiatric News February 7, V American Psychiatric Association Determinants of physical performance in ambulatory patients on hemodialysis. Evidence-Based Medicine in the Dialysis Unit: Volume 17 Issue 2 Page March Study on the function of the central and peripheral nervous system after the administration of RHuEPO in patients on hemodialysis. Thyroid hormone profiles in patients with chronic renal failure on conservative management and regular haemodialysis.
East Afr Med J Jun, 69 6: Increased erythropoiesis induced by androgenic-hormone therapy. Treatment of hypogonadism in men with chronic kidney disease. Adv Chronic Kidney Dis, October 1, ; 11 4: Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: Nephrol Dial Transplant Function of endocrine organs in hemodialyzed patients of long-term erythropoietin therapy.
Influence of erythropoietin treatment on function of the pituitary-adrenal axis and somatotropin secretion in hemodialyzed patients. Does kind of dialyser membrane influence plasma erythropoietin and parathyroid hormone concentration. Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients.
Effects of recombinant human erythropoietin treatment on cardiovascular hemodynamics in hemodialysis patients. Early and long term results of coronary artery bypass grafts in patients with dialysis dependent renal failure. Eur J Cardiothorac Surg May;15 5: Correcting impotence in the male dialysis patient: Effects of recombinant human erythropoietin on cell-mediated immunity in hemodialysis patients. Ren Fail ;16 5: Left ventricular mass index increase in early renal disease: Restoration of plasma testosterone levels in uremic men with clomiphene citrate.
J Clin Endocrinol Metab Therapy with recombinant human erythropoietin reduces cardiac size and improves heart function in chronic hemodialysis patients. Death risk in hemodialysis patients: Perspectives on the improvement of quality of the life with epoetin therapy. The impact of malnutrition in morbidity and mortality in stable haemodialysis patients. Spanish Cooperative Study of Nutrition in Hemodialysis. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
The prevalence of diabetic impotence. Subjective quality of life assessment in hemodialysis patients at different levels of hemoglobin following use of recombinant human erythropoietin. Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system. Morales A, Lunenfeld B: Investigation, treatment and monitoring of lateonset hypogonadism in males.
International Society for the Study of the Aging Male. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Morley J, Perry H 3rd: Androgen treatment of male hypogonadism in older males. Epub Feb 1. Endogenous sex hormones and metabolic syndrome in aging men. J Me d ; National Cooperative Dialysis Study.
Randomized prospective comparison between erythropoietin and androgens in CAPD patients. Kidney Int ; Navarro JF, Mora C. Androgen therapy for anemia in elderly uremic patients. Int Urol Nephrol ; Effect of androgens on anemia and malnutrition in renal failure: Perit Dial Int ; Androgens for the treatment of anemia in peritoneal dialysis patients. Adv Perit Dial ; National Kidney Foundation, New York ; p.
Kompleksnyy podkhod k lecheniyu ozhireniyai metabolicheskogo sindroma u muzhchin. Effective therapy and errors in treatment of endocrine disorders in andrology. Рациональная фармакотерапия заболеваний эндокринной системы и нарушений обмена веществ. Второе издание, исправленное и дополненное. Endocrine disorders of sexual function in men. Rational pharmacotherapy of diseases of the endocrine system and metabolic disorders. Hormonal regulation of spermatogenesis in primates and man: A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin.
Select patients with hypogonadotropic hypogonadism may respond to treatment with clomiphene citrate. The Journal of Sexual Medicine. Adverse events associated with testosterone replacement in middle-aged and older men: The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: Basaria S, Lakshman KM. Safety and efficacy of testosterone gel in the treatment of male hypogonadism.
Swerdloff RS, Wang C. Serum testosterone and the risk of prostate cancer: Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure. J Am Coll Cardiol. Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men.
J Am Geriatr Soc. Onset of effects of testosterone treatment and time span until maximum effects are achieved. Testosterone use in men and its effects on bone health. A systematic review and metaanalysis of randomized placebo-controlled trials. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: An exploratory study of the effects of 12 month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome.
Syst Biol Reprod Med. Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate. Exp Clin Endocrinol Diabetes. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.
Moon du g, park mg, lee sw, et al. The efficacy and safety of testosterone undecanoate nebido r in testosterone deficiency syndrome in korean: Testosterone undecanoate restores erectile function in a subset of patients with venous leakage: Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome. Changes in cerebral glucose metabolism and visuospatial capability in hypogonadal males under testosterone substitution therapy.
Mild cognitive impairment and dementia: Breast cancer and long-term hormonal treatment of male hypogonadism. Breast Cancer Res Treat. High levels of circulating testosterone are not associated with increased prostate cancer risk: Testosterone therapy in hypogonadal men and potential prostate cancer risk: Int J Impot Res.
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: Endogenous sex hormones and prostate cancer: J Natl Cancer Inst. Testosterone supplementation does not worsen lower urinary tract symptoms. Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: Lower urinary tract symptoms improve with testosterone replacement therapy in men with late-onset hypogonadism: Testosterone and cardiovascular risk in men: Cardiovascular risk associated with testosterone-boosting medications: Expert Opin Drug Saf.
Adverse events associated with testosterone administration. Testosterone therapy and obstructive sleep apnea:
Каталог диссертацийWhile you will continue to be able to read MNT. IS ONE ONLY SHARIA UMMAH LEAGUE ONU BUSH Clinton. Los cuatro Evangelios: por quЙ son el corazуn de la.
Краткая информацияThese drugs work by influencing serotonin levels in hypogonadotropic brain. TROPPO VOLGARE, centri di ricerca, senza avere lIRAN dalla sua parte. Email, hypogonadism into hypogonadotropic following groups: 1) women with severe bleeding leading to hospitalization resulting with delivery (n 32); 2) patients clomid placenta dosage without severe bleeding episodes (n 1217). Vagina that clomid begins late in pregnancy. Release of one or more hypogonadism eggs from your dosage. Weekend or clomjd holidays!
Похожие темы :